← Back
Data updated: Mar 10, 2026
SHANDONG XINHUA
Pharmaceuticals
SHANDONG XINHUA is a generic drug manufacturer with 3 FDA-approved products.
2016
Since
3
Drugs
-
Trials
91
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ATORVASTATIN CALCIUM 2026-01-22
Manufacturing (CMC)
ATORVASTATIN CALCIUM 2025-12-31
Labeling
ATORVASTATIN CALCIUM 2025-11-13
SEVELAMER CARBONATE 2025-10-27
IBUPROFEN 2025-04-29
Manufacturing (CMC)
SEVELAMER CARBONATE 2025-04-24
Labeling
IBUPROFEN 2025-04-01
Labeling
IBUPROFEN 2025-04-01
Labeling
IBUPROFEN 2025-04-01
Labeling
IBUPROFEN 2025-03-20
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (1)
Company Info
- First Approval
- 2016-11-23
- Latest
- 2024-11-21
- Applications
- 4